Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
A technology used to develop new medical treatments might one day revive endangered or extinct species.
A new study reveals the influence of large RNA molecules in controlling stem cells.
A small biotech firm is the second company to start human tests of embryonic stem-cell therapy.
Researchers create carbon nanotubes that mimic natural tissue and can regenerate heart cells in a dish.
Reprogrammed stem cells from schizophrenia patients could help researchers study the disease more closely, and test drugs to fight it.
Embryonic stem cells growing in a dish can spontaneously form complex structures resembling the retina—a discovery that could one day help restore sight to the blind.
The findings cast doubt on a promising alternative to the use of embryonic stem cells in medicine.
A company is testing whether stem cells from fat could help prevent long-term damage after a heart attack.
Polymer threads coated with stem cells might one day heal damaged cardiac muscle.
“Building blocks” containing gels turn cells into different types of tissue.